Frank Rimerman Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Frank Rimerman Advisors's MRNA Position: Q2 2026 in Review
Frank Rimerman Advisors opened a new position in Moderna (MRNA) in Q2 2026: 3,880 shares worth $272K. The stake represents 0.02% of the portfolio and ranks #536 among its holdings. This is a return to the name: Frank Rimerman Advisors previously reported a position in MRNA as recently as Q2 2024.
Frank Rimerman Advisors first reported a position in MRNA in Q3 2021 and has held it in 4 quarters since. The position peaked at $374K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Frank Rimerman Advisors held 3,880 shares of Moderna worth $272K as of Q2 2026.
- Moderna was a new Frank Rimerman Advisors position in Q2 2026.
- Moderna made up 0.02% of Frank Rimerman Advisors's portfolio in Q2 2026, its #536 holding.
- Frank Rimerman Advisors first reported a position in Moderna in Q3 2021 and has held it in 4 quarters since.
- Frank Rimerman Advisors's Moderna position peaked at $374K in Q2 2024.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.